Accolade, Inc. (ACCD): Forward P/S Multiple

Corporate company logo of Accolade, Inc. (ACCD)

Accolade focuses on organic growth within the corporate B2B segment by developing IT integrations with insurance companies. Analyzing the chart on GURU.Markets, we note that the forward P/S trajectory has reached the 1.30 level, confirming market confidence in the model's scalability. This is supported by a strong corporate culture and commitment to personnel, as well as unique healthcare benefit navigation that saves costs for the largest US employers.

Accolade, Inc. - ACCD Market Cap to Future Revenue Ratio (period 07/04/2022 - 04/19/2025)

Summary analytical data breakdowns for accolade.com (ACCD)

- current price and projected stock value:
Stock Price Accolade, Inc.|ACCD - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Capitalization ACCD|ACCD - Business Value
- issuer book value statistics:
Book Value per Share Accolade|ACCD - Total Stockholders' Equity|Market Capitalization to Book Value Ratio accolade.com|ACCD - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Accolade|ACCD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Accolade, Inc.|ACCD - Company Total Debt|Debts to Book Capitalization ACCD|ACCD - Company Long-Term Indebtedness|Company Current Liabilities Accolade|Quick Ratio accolade.com
- financial results and valuation multiples details:
ACCD - Company Net Income|Expected Profit Accolade|ACCD - Price to Earnings Ratio|Forward P/E Multiple Accolade, Inc.|ACCD - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ACCD|ACCD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Accolade|ACCD - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth accolade.com|ACCD - Earnings per share growth this year|Earnings growth forecast for next year Accolade
- revenue and sales details:
ACCD - Revenue and Sales Volume|Projected Sales Volume Accolade, Inc.|ACCD - Market Cap to Revenue|Forward P/S Multiple ACCD
Analysis of all company metrics:Accolade Health ACCD
Product sample of accolade.com

The scalability of the Accolade (ACCD) cloud platform via AI-sorting and self-service directly impacts the forward P/S history, reflecting the market's valuation of future sales efficiency. This indicator is calculated as the ratio of current market capitalization to expected revenue, capturing investor reaction to the cost of capital; reaching historical highs signals that the asset is overbought and carries a high risk of correction.

Competitor analysis for Accolade

Forward P/S Multiple HIMS (Hims & Hers)|Forward P/S Multiple Hinge Health, Inc. HNGE|Teladoc Inc. - Forward P/S Multiple|TALK (Talkspace Platform) - Market Cap to Projected Revenue|LFMD: Forward P/S Multiple|Market Cap to Future Revenue Ratio amwell.com (AMWL)|MGRX (Mangoceuticals Inc.) - Forward P/S Multiple|Forward P/S Multiple DarioHealth Corp|Forward P/S Multiple VSEE|Forward Price-to-Revenue Multiple Mobile-health Corp MNDR|Forward P/S Multiple BTCY (Biotricity, Inc.)|LYT - Forward Price-to-Revenue Multiple|Ontrak - Forward P/S Multiple|SHLT (SHL Telemedicine Ltd.) - Market Cap to Projected Revenue|THRN (Thorne) - Forward Price-to-Revenue Multiple